Trial intelligence / Profile preview

Oral clonidine for pain control in adults with orthopedic fractures

IRCT20220822055774N1Phase 3Completed

Sponsor
Kerman University of Medical Sciences
Start
Nov 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, triple-blind trial of clonidine in bone fracture (Fx), sponsored by Kerman University of Medical Sciences. Started Nov 2022; status: completed.

02

Drugs

clonidine
03

Conditions

bone fracture (Fx)

Beyond the preview

Go deeper on IRCT20220822055774N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220822055774N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call